Table 4.
Top IPA pathways potentially regulated by histone modifications and disrupted in 10-wk IUGR islets.
Histone Mark | Ingenuity Canonical Pathways | p-Value |
---|---|---|
H3K4me3 | Type II Diabetes Mellitus signaling | 1.32 × 10−4 |
antiproliferative role of TOB in T- cell signaling | 7.24 × 10−4 | |
Tight junction signaling | 1.00 × 10−3 | |
RAR activation | 1.12 × 10−3 | |
PI3K signaling in B lymphocytes | 1.23 × 10−3 | |
Factors promoting cardiogenesis in vertebrates | 1.23 × 10−3 | |
BMP signaling pathway | 1.41 × 10−3 | |
Neurotrophin/TRK signaling | 1.51 × 10−3 | |
PPAR signaling | 1.55 × 10−3 | |
H3K27me3 | Cellular stress and injury | 2.24 × 10−7 |
Hepatic fibrosis / hepatic stellate cell activation | 1.41 × 10−6 | |
cAMP-mediated signaling | 1.32 × 10−5 | |
Macrophage function | 2.95 × 10−5 | |
Mitochondrial function / Autophagy | 3.55 × 10−5 | |
Citrulline-nitric oxide cycle | 3.63 × 10−5 | |
Wnt/β-catenin signaling | 8.13 × 10−5 | |
Axonal guidance signaling | 9.12 × 10−5 | |
eNOS signaling | 3.63 × 10−4 | |
H3K27Ac | Polyamine regulation | 1.78 × 10−6 |
Cell migration signaling | 1.02 × 10−5 | |
Production of nitric oxide and reactive oxygen species in Macrophages | 1.05 × 10−5 | |
IL-9 signaling | 1.35 × 10−5 | |
PDGF signaling | 3.24 × 10−5 | |
PPAR signaling | 4.90 × 10−5 | |
Unfolded protein response | 5.13 × 10−5 | |
ERK/MAPK signaling | 6.46 × 10−5 | |
Phospholipase C signaling | 1.12 × 10−4 |